Description
Identify which schedules and adjuvants rescue durability rather than only peak immunogenicity in older adults. Boundary domains: vaccinology, clinical-immunology. Representative papers: Heterogeneity of memory T cells in aging.; Durability of humoral immune responses to rubella following MMR vaccination.; Analysis of humoral and cellular immune activation up to 21 months after heterologous and homologous COVID-19 vaccination.